Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Ohman

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Heart (British Cardiac Society)|September 17, 2002
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteriesC-K Wong, H D White, R G Wilcox, et al.
The American Journal of Cardiology|March 15, 1996
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyK W Mahaffey, C B Granger, R Collins, et al.
The American Journal of Cardiology|May 1, 1995
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study GroupA M Lincoff, E J Topol, R M Califf, et al.
European Heart Journal|September 3, 2004
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACSJ P Ottervanger, P Armstrong, E S Barnathan, et al.
American Heart Journal|September 1, 1992
Coronary angioplasty performed with gradual and prolonged inflation using a perfusion balloon catheter: procedural success and restenosis rateA N Tenaglia, P J Quigley, D J Kereiakes, et al.
Cardiology|July 15, 2000
Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we?G V Nair, P A Gurbel, S Y Fuzaylov, et al.
Journal of the American College of Cardiology|August 1, 1993
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot StudyN S Kleiman, E M Ohman, R M Califf, et al.
Circulation|September 1, 1990
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study GroupE M Ohman, R M Califf, E J Topol, et al.
Journal of Thrombosis and Thrombolysis|December 10, 1999
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarctionN S Kleiman, R P Tracy, J D Talley, et al.
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Heart (British Cardiac Society)|September 17, 2002
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteriesC-K Wong, H D White, R G Wilcox, et al.
The American Journal of Cardiology|March 15, 1996
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyK W Mahaffey, C B Granger, R Collins, et al.
The American Journal of Cardiology|May 1, 1995
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study GroupA M Lincoff, E J Topol, R M Califf, et al.
European Heart Journal|September 3, 2004
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACSJ P Ottervanger, P Armstrong, E S Barnathan, et al.
American Heart Journal|September 1, 1992
Coronary angioplasty performed with gradual and prolonged inflation using a perfusion balloon catheter: procedural success and restenosis rateA N Tenaglia, P J Quigley, D J Kereiakes, et al.
Cardiology|July 15, 2000
Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we?G V Nair, P A Gurbel, S Y Fuzaylov, et al.
Journal of the American College of Cardiology|August 1, 1993
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot StudyN S Kleiman, E M Ohman, R M Califf, et al.
Circulation|September 1, 1990
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study GroupE M Ohman, R M Califf, E J Topol, et al.
Journal of Thrombosis and Thrombolysis|December 10, 1999
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarctionN S Kleiman, R P Tracy, J D Talley, et al.
Chest|February 7, 2001
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safetyJ Hirsh, T E Warkentin, S G Shaughnessy, et al.
Pageof 15